Alain Braillonis currentlychief of an Alcohol Treatment Unit (Department of Medicine, Amiens, France).He receivedhis medical degree in and obtained a PhD (DERBH) from the University of Paris-Diderot and a Board Certification in Gastroenterology in 1984. He completed his chief fellowship in Hepatologyand was Assistant Professorfrom 1984 to1986(Amiens University) and then after post-doctoral fellow at the Department of Pharmacology and the Cardiovascular Center at the University of Iowa. He obtained a tenure position at the Institut National de la Santé et de la RechercheMédicale(French NIH) in 1987 as an Associate Director of Research (Hepatic Hemodynamics Unit, Beaujon hospital). In 1990 he served as a senior research administrator (AP-HP, Paris Public Hospitals Authority), participating to the creation of the first Clinical Research Division in a French university hospital, a program which has been nationally implemented then after. From 2002–2003 he was chief of the Transparency unit (drug evaluation for reimbursement & pricing) at the Medicine Agency (Afssaps, French FDA). In 2004 he obtained a tenure position as a senior consultant andserved as director for quality and security of care(Department of Public Health, Picardy Regional Office for Health), also being regional advisor for the National Authority for Quality in Health Care. In 2009 he was sacked for blowing the whistle by the Ministry of Health, meanwhile his boss, Pr Dubois (chairman of the Addiction Committee at the National Academy of Medicine) was sued for libel by the Tobacconists’ Union.(WittonJ, O’Reilly J.Tobacco scientistwins case against illegalsacking.He is author or co-author of more than 270 scientific publications referenced in Pubmed. His specific interests are tobacco and alcohol control.
2) Alcohol control.